MEDVi
Reviewed by Iacob Pastina, Independent Researcher
Compounded GLP-1 platform offering both oral and injectable options with flexible dosing and affordable pricing.
MEDVi scores 7.7/10 in our independent review, starting at $299/mo for compounded GLP-1 medications. MEDVi carves out a niche by offering both oral and injectable compounded semaglutide — a combination most competitors don't provide. If you're needle-averse but want to eventually transition to injectables (which generally show better bioavailability), MEDVi lets you do that within one platform.
Quick Facts
What We Like
- +One of the few compounded providers offering both oral tablets and injectable semaglutide
- +Micro-dosing options available — can start at sub-standard doses for patients concerned about side effects
- +Sleek onboarding experience with clear progress tracking through their patient portal
- +$179/mo is competitive for a platform with both oral and injectable compounded formulations
What Could Be Better
- −Compounded medications only — no path to brand-name Wegovy or Zepbound through their platform
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
✓Best For
- •Needle-averse users who want to start with oral and potentially transition to injectable
- •Patients with GI sensitivity who want micro-dosing below standard protocols
- •Users who value a sleek digital experience with progress tracking
✗Not Ideal For
- •Users who want brand-name FDA-approved medications
- •Those who need insurance billing
- •Patients who want tirzepatide (MEDVi only offers semaglutide)
How MEDVi Works
Health Assessment + Preference Selection
Complete your health profile and indicate your preference for oral tablets or injectable semaglutide. MEDVi's intake specifically addresses needle concerns and GI sensitivity.
Provider Consultation + Micro-Dose Option
Your provider reviews your profile and can start you at micro-doses below standard protocols if you're concerned about side effects. Oral or injectable — your choice.
Treatment + Progress Tracking
Medication ships free. Track your weight, side effects, and milestones through MEDVi's patient portal. Transition from oral to injectable anytime.
Medications Available
Pricing Details
Oral Compounded Semaglutide
$179/moOral semaglutide tablets with consultations, shipping, and portal access
Injectable Compounded Semaglutide
$179/moInjectable semaglutide with consultations, shipping, and portal access
Oral + Injectable Transition
$179/moStart oral, transition to injectable at any point — same price throughout
Cancellation policy: Cancel anytime with 7-day notice
Ready to get started?
Visit MEDViOur Verdict
MEDVi is the best option for needle-averse users who want a clear pathway from oral to injectable GLP-1 treatment. The micro-dosing options and sleek portal add genuine value. The limitation is semaglutide-only — no tirzepatide, no brand-name. But for users who specifically want flexibility between oral and injectable compounded semaglutide, MEDVi is purpose-built for that journey.
Key differentiator: The only compounded GLP-1 platform offering a structured oral-to-injectable transition pathway with micro-dosing options for side-effect-sensitive patients.
Frequently Asked Questions
How effective is oral compounded semaglutide vs. injectable?+
What is micro-dosing and how does it work?+
Can I switch from oral to injectable mid-treatment?+
Does MEDVi offer tirzepatide?+
Alternatives to MEDVi
Similar providers by type, price, and features
Helpful Tools
MEDVi
From $299/mo